APBA3
Amyloid-beta A4 precursor protein-binding family A member 3
Also known as: APBA3_HUMAN, mint3, X11L2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O96018
- Gene
- APBA3
- Ensembl
- ENSG00000011132
- Chromosome
- 19
- Canonical length
- 575 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a member of the X11 protein family. It is an adapter protein that interacts with the Alzheimer's disease amyloid precursor protein. This gene product is believed to be involved in signal transduction processes. This gene is a candidate gene for Alzheimer's disease. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
575 residues, UniProt reviewed canonical sequence.
>O96018|APBA3
1 MDFPTISRSP SGPPAMDLEG PRDILVPSED LTPDSQWDPM PGGPGSLSRM ELDESSLQEL
61 VQQFEALPGD LVGPSPGGAP CPLHIATGHG LASQEIADAH GLLSAEAGRD DLLGLLHCEE
121 CPPSQTGPEE PLEPAPRLLQ PPEDPDEDSD SPEWVEGASA EQEGSRSSSS SPEPWLETVP
181 LVTPEEPPAG AQSPETLASY PAPQEVPGPC DHEDLLDGVI FGARYLGSTQ LVSERNPPTS
241 TRMAQAREAM DRVKAPDGET QPMTEVDLFV STKRIKVLTA DSQEAMMDHA LHTISYTADI
301 GCVLVLMARR RLARRPAPQD HGRRLYKMLC HVFYAEDAQL IAQAIGQAFA AAYSQFLRES
361 GIDPSQVGVH PSPGACHLHN GDLDHFSNSD NCREVHLEKR RGEGLGVALV ESGWGSLLPT
421 AVIANLLHGG PAERSGALSI GDRLTAINGT SLVGLPLAAC QAAVRETKSQ TSVTLSIVHC
481 PPVTTAIIHR PHAREQLGFC VEDGIICSLL RGGIAERGGI RVGHRIIEIN GQSVVATPHA
541 RIIELLTEAY GEVHIKTMPA ATYRLLTGQE QPVYLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against APBA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 14 nTPM
- spleen: 10 nTPM
- liver: 9.7 nTPM
- ovary: 8.7 nTPM
- kidney: 7.9 nTPM
- salivary gland: 7.9 nTPM
Single-cell type
- enterocytes: 20 nCPM
- syncytiotrophoblasts: 19 nCPM
- esophageal apical cells: 17 nCPM
- esophageal suprabasal cells: 16 nCPM
- extravillous trophoblasts: 15 nCPM
- decidual stromal cells: 14 nCPM
Immune cell
- T-reg: 20 nTPM
- gdT-cell: 13 nTPM
- memory CD4 T-cell: 13 nTPM
- memory CD8 T-cell: 13 nTPM
- MAIT T-cell: 12 nTPM
- naive B-cell: 12 nTPM
Brain region
- white matter: 9.9 nTPM
- medulla oblongata: 8 nTPM
- basal ganglia: 7 nTPM
- cerebral cortex: 7 nTPM
- cerebellum: 6.6 nTPM
- midbrain: 6.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- 0.2
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- in utero embryonic development
- negative regulation of catalytic activity
- protein transport
- regulation of gene expression
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of APBA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APBA3 as an antibody target. Whether an autoantibody or antibody against APBA3 could matter depends on whether native APBA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APBA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label APBA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...